FIT Biotech Oy
Company release 3.1.2019 at 15:30 EET
Changes in FIT Biotech's Board of Directors
Juhani Pitkäkoski has resigned because of personal reasons from FIT Biotech Oy's ("Company", FITBIO: FN Finland) Board of Directors. Pitkäkoski has served as a member of FIT Biotech's Board of Directors since 2018.
Chitra Bharucha, Chairman of the Board of Directors, comments:
"I want to thank Juhani for the work he has done in the company's Board of Directors."
FIT Biotech Oy
Board of Directors
For further information:
Chitra Bharucha
Chairman of the Board of Directors
Tel: +44 7736 679347
Email: chitra@fitbiotech.com
Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000
FIT Biotech in brief
FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.
FIT Biotech applies its GTU® technology in its development projects, which at the time include gene-based treatments, genetic vaccines and research collaboration. Application areas include cancer (gene therapy) and infectious diseases such as HIV.
FIT Biotech K-shares are listed on the First North Finland market maintained by Nasdaq Helsinki Ltd.
DISTRIBUTION:
Nasdaq Helsinki
Principal media
www.fitbiotech.com